Cargando…

Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa

BACKGROUND: Although direct-acting antivirals (DAA) have become standard care for patients with chronic hepatitis C worldwide, there is no evidence for their value for money in sub-Saharan Africa. We assessed the cost-effectiveness of four sofosbuvir-based regimens recommended by the World Health Or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyer, Sylvie, Baudoin, Maël, Nishimwe, Marie Libérée, Santos, Melina, Lemoine, Maud, Maradan, Gwenaëlle, Sylla, Babacar, Kouanfack, Charles, Carrieri, Patrizia, Mourad, Abbas, Rouveau, Nicolas, Moh, Raoul, Seydi, Moussa, Attia, Alain, Woode, Maame Esi, Lacombe, Karine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897946/ https://www.ncbi.nlm.nih.gov/pubmed/35248039 http://dx.doi.org/10.1186/s12913-021-07289-0

Ejemplares similares

Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial)
por: Marcellin, Fabienne, et al.
Publicado: (2022)

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)
por: Bousmah, Marwân-al-Qays, et al.
Publicado: (2020)

Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa
por: Duchesne, Léa, et al.
Publicado: (2020)

Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey)
por: Périères, Lauren, et al.
Publicado: (2021)

Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon
por: Bousmah, Marwân-al-Qays, et al.
Publicado: (2021)

Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”
por: Giannelos, Nikolaos, et al.
Publicado: (2022)

Equity and efficiency in the scaled-up implementation of integrated neglected tropical disease control: the health economics protocol of the COUNTDOWN multicountry observational study in Ghana, Cameroon and Liberia
por: Woode, Maame Esi, et al.
Publicado: (2018)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
por: Liégeois, Florian, et al.
Publicado: (2020)

The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study)
por: Gosset, Andréa, et al.
Publicado: (2021)

Sofosbuvir and daclatasvir
por: Hessel, Marleen H. M., et al.
Publicado: (2016)

Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study)
por: Roux, Perrine, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)
por: Garay, Osvaldo Ulises, et al.
Publicado: (2019)

Job satisfaction among community drug distributors in the Mass Drug Administration programme in Nigeria: a cross-sectional study
por: Kevin, Diltokka Gideon, et al.
Publicado: (2023)

Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
por: Roux, Perrine, et al.
Publicado: (2017)

Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial)
por: Nordmann, Sandra, et al.
Publicado: (2017)

The Evolution of the Hallmarks of Aging
por: Lemoine, Maël
Publicado: (2021)

A Community-Based Therapeutic Education Programme for People with Alcohol Use Disorder in France: A Qualitative Study (ETHER)
por: Costa, Marie, et al.
Publicado: (2022)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Sofosbuvir Thio-analogues: Synthesis and Antiviral Evaluation of the First Novel Pyridine- and Pyrimidine-Based Thioglycoside Phosphoramidates
por: Abu-Zaied, Mamdouh Attia, et al.
Publicado: (2020)

Sofosbuvir: A Potential Treatment for Ebola
por: Reznik, Sandra E., et al.
Publicado: (2018)

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Potential Use of Sofosbuvir in the Prophylaxis for Rabies
por: Reznik, Sandra E., et al.
Publicado: (2020)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
por: Shin, Hyun Phil
Publicado: (2023)

Individual and healthcare supply-related HIV transmission factors in HIV-positive patients enrolled in the antiretroviral treatment access program in the Centre and Littoral regions in Cameroon (ANRS-12288 EVOLCam survey)
por: Coulaud, Pierre-julien, et al.
Publicado: (2022)

Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression
por: Belzung, Catherine, et al.
Publicado: (2011)

Decomposition of the decoupling of CO(2) emissions from economic growth in Ghana
por: Oteng-Abayie, Eric Fosu, et al.
Publicado: (2022)

Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
por: Buggisch, Peter, et al.
Publicado: (2019)

Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
por: Heo, Jeong, et al.
Publicado: (2023)

Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level
por: Lô, Gora, et al.
Publicado: (2019)

Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort
por: Kutala, Blaise K, et al.
Publicado: (2017)

Adherence as a Predictor of Sexual Behaviors in People Living with HIV/AIDS during the First Year of Antiretroviral Therapy in Rural Cameroon: Data from Stratall ANRS 12110/ESTHER Trial
por: Ndziessi, Gilbert, et al.
Publicado: (2012)

GWENA: gene co-expression networks analysis and extended modules characterization in a single Bioconductor package
por: Lemoine, Gwenaëlle G., et al.
Publicado: (2021)

Philosophy of medicine in 2021
por: Simon, Jeremy R., et al.
Publicado: (2022)

Sofosbuvir Has Come Out of the Magic Box
por: Alavian, Seyed Moayed
Publicado: (2013)

A bibliometric analysis of the global research on sofosbuvir
por: Hernández-Vásquez, Akram, et al.
Publicado: (2017)

Use of sofosbuvir in chronic kidney disease: Is it necessary?
por: Lim, Tae Seop, et al.
Publicado: (2017)

Acute Interstitial Nephritis Associated with Sofosbuvir and Daclatasvir
por: Ashraf, Taha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7n4nhl8jppvmigplos9jh1ok5a